EA201791702A1
(ru)
|
|
Терапевтические средства на основе гликанов и связанные с ними способы
|
MY187047A
(en)
|
|
Selective pyy compounds and uses thereof
|
MX2017000143A
(es)
|
|
Composiciones enriquecidas estereoquimicamente para administracion de acidos nucleicos.
|
WO2014180889A8
(en)
|
|
Methods and compositions for the treatment of cancer
|
IL283539A
(en)
|
|
3,3-difluoroallylamines or their salts and pharmaceutical preparations containing them
|
BR112017028140A2
(pt)
|
|
formulações farmacêuticas
|
WO2015171558A3
(en)
|
|
BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE
|
IL280376A
(en)
|
|
The history of boronic acid, its preparation and pharmaceutical preparations containing it
|
EP3213746A4
(en)
|
|
Pharmaceutical composition for oral administration comprising taxane
|
WO2016140933A3
(en)
|
|
Immediate release soluble ibuprofen compositions
|
IL272806B1
(en)
|
|
The history of boronic acid, its preparation and pharmaceutical preparations containing it
|
EA201991287A1
(ru)
|
|
Твердые фармацевтические композиции на основе тикагрелора для перорального применения
|
EP3539978A4
(en)
|
|
NKX3.2 FRAGMENT AND PHARMACEUTICAL COMPOSITION WITH IT AS THE ACTIVE INGREDIENT
|
MX2018014129A
(es)
|
|
Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato.
|
HK1255345A1
(zh)
|
|
含有高濃度紫杉烷的用於口服給藥的藥物組合物
|
EP3626712A3
(en)
|
|
Liver x receptor (lxr) modulators
|
MX2022013541A
(es)
|
|
Composiciones de acido gamma-poliglutamico y zinc.
|
WO2015159155A3
(en)
|
|
Novel ademetionine formulations
|
EA201991286A1
(ru)
|
|
Твердая фармацевтическая композиция для перорального применения, содержащая тенофовир и эмтрицитабин
|
TH174485B
(th)
|
|
ผลิตภัณฑ์สำหรับการนำส่งทางปาก
|
WO2017079403A3
(en)
|
|
Polymeric nanoparticles
|
TH174485A
(th)
|
|
ผลิตภัณฑ์สำหรับการนำส่งทางปาก
|
PT3845230T
(pt)
|
|
Composição farmacêutica para administração oral
|
HUE062682T2
(hu)
|
|
Ibuprofén tartalmú orális gyógyszerészeti készítmény
|
EP3888647A4
(en)
|
|
EZH1/2 DUAL INHIBITOR CONTAINING PHARMACEUTICAL COMPOSITION FOR USE AS COMBINATION MEDICINAL PRODUCT
|